PRAX

Praxis Precision Medicines Inc. Common Stock (PRAX)

Stock · NASDAQ · Health Care

$344.75as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$314.32
Industry
Biotechnology: Pharmaceutical Preparations

How Praxis Precision Medicines Inc. Common Stock Makes Money

Where the revenue actually goes — FY2024 annual results

market-wall.comTotalRevenue$8.55MR&D$152.41M (1782%)SG&A$56.30M (658%)PRAX

Source: 10-K filed Feb 28, 2025 · via SEC EDGAR / Finnhub

Praxis Precision Medicines Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • PRAX
    Praxis Precision Medicines Inc. Common Stock
    $344.95
    ▼ 6.23%
    Market cap $8.52BP/E
  • SYRE
    Spyre Therapeutics Inc. Common Stock
    $90.4
    ▼ 3.43%
    Market cap $8.35BP/E
    $14.51$110.18
  • CYTK
    Cytokinetics Incorporated Common Stock
    $72.17
    ▼ 7.36%
    Market cap $9.51BP/E
    $35.22$88.31
  • COGT
    Cogent Biosciences Inc. Common Stock
    $34.68
    ▼ 6.50%
    Market cap $6.64BP/E
    $11.6$43.73
  • SMMT
    Summit Therapeutics Inc. Common Stock
    $13.71
    ▼ 4.33%
    Market cap $10.41BP/E
    $12.07$29.23
  • MIRM
    Mirum Pharmaceuticals Inc. Common Stock
    $97.44
    ▼ 2.32%
    Market cap $6.38BP/E
    $63.23$130
  • ABVX
    Abivax SA American Depositary Shares
    $113.41
    ▼ 0.78%
    Market cap $10.74BP/E
    $60.45$139

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
31.45M
Total value held
$9.86B
Institutional holders
290
Top holders this quarter
  • Unknown3.46M
  • Unknown2.47M
  • Unknown2.32M
  • Unknown2.16M
  • Unknown2.04M
  • Unknown1.75M
  • Unknown1.22M
  • Unknown963.4K
  • Unknown949.2K
  • Unknown885.5K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.